Sorry, you need to enable JavaScript to visit this website.

dhcf

Department of Health Care Finance - DHCF
 

DC Agency Top Menu

-A +A
Bookmark and Share

Transmittal 24-16-Suboxone and Buprenorphine-Containing Products Daily Dosing Limit Increase


Friday, April 19, 2024

The purpose of this transmittal is to inform facilities and providers about a change in the District of Columbia’s (DC’s) Suboxone and Buprenorphine-containing products daily dosing limit. Effective May 1, 2024, the daily dosing limit for Suboxone and Buprenorphine-containing products without a prior authorization will increase to 32mg. The current daily dosing limit is 24mg.